ABCL | AbCellera Biologics Inc.

Index- P/E- EPS (ttm)-0.18 Insider Own19.70% Shs Outstand287.77M Perf Week-1.74%
Market Cap1.96B Forward P/E- EPS next Y-0.66 Insider Trans0.45% Shs Float203.83M Perf Month3.03%
Income-50.20M PEG- EPS next Q-0.13 Inst Own46.90% Short Float / Ratio13.06% / 13.02 Perf Quarter-18.97%
Sales181.00M P/S10.83 EPS this Y4.40% Inst Trans11.32% Short Interest26.62M Perf Half Y-47.24%
Book/sh4.20 P/B1.62 EPS next Y-11.90% ROA-3.20% Target Price26.67 Perf Year-12.95%
Cash/sh0.67 P/C10.16 EPS next 5Y10.00% ROE-4.10% 52W Range5.53 - 14.97 Perf YTD-32.97%
Dividend- P/FCF32.67 EPS past 5Y- ROI11.00% 52W High-54.64% Beta-
Dividend %- Quick Ratio10.50 Sales past 5Y- Gross Margin- 52W Low22.78% ATR0.41
Employees495 Current Ratio10.50 Sales Q/Q-96.10% Oper. Margin-40.50% RSI (14)53.90 Volatility6.10% 6.83%
OptionableYes Debt/Eq0.00 EPS Q/Q-125.80% Profit Margin-27.70% Rel Volume1.15 Prev Close6.79
ShortableYes LT Debt/Eq0.00 EarningsMay 04 AMC Payout0.00% Avg Volume2.05M Price6.79
Recom1.80 SMA208.05% SMA50-0.49% SMA200-29.62% Volume2,357,438 Change0.00%
Date Action Analyst Rating Change Price Target Change
Feb-28-23Initiated Cowen Outperform
Dec-15-22Initiated Goldman Buy $30
Nov-16-22Initiated Truist Buy $29
Dec-21-21Initiated The Benchmark Company Buy $27
Nov-19-21Initiated Piper Sandler Overweight $33
Jan-05-21Initiated SVB Leerink Outperform $45
Jan-05-21Initiated Stifel Buy $59
Jan-05-21Initiated Credit Suisse Outperform $52
Jan-05-21Initiated BMO Capital Markets Outperform $48
Jan-05-21Initiated Berenberg Buy $53
May-30-23 06:50AM
May-29-23 04:05PM
May-27-23 08:43AM
May-24-23 02:32PM
01:30PM Loading…
May-14-23 02:57PM
May-06-23 08:03AM
May-05-23 10:13AM
May-04-23 05:15PM
Apr-27-23 10:02AM
Apr-24-23 07:46PM
Apr-17-23 09:10AM
05:50AM Loading…
Apr-13-23 05:50AM
Apr-11-23 07:31PM
Apr-06-23 04:05PM
Apr-05-23 01:40PM
Mar-22-23 03:26PM
Mar-14-23 04:30PM
Mar-12-23 08:09AM
Feb-23-23 04:05PM
Feb-21-23 10:30PM
Feb-02-23 02:19PM
Feb-01-23 04:05PM
04:05PM Loading…
Jan-24-23 04:05PM
Jan-23-23 11:00AM
Jan-19-23 07:00PM
Jan-12-23 04:55AM
Jan-05-23 09:09AM
Jan-04-23 04:05PM
Dec-22-22 05:08AM
Dec-21-22 06:46AM
Dec-16-22 10:02AM
Dec-15-22 07:00AM
Dec-14-22 08:18AM
Dec-12-22 08:54AM
Dec-01-22 07:00AM
Nov-29-22 04:10PM
Nov-10-22 08:05AM
Nov-08-22 11:00PM
Nov-04-22 04:05PM
Nov-03-22 01:45PM
Nov-02-22 09:00AM
Nov-01-22 10:01AM
Oct-25-22 02:45PM
Oct-21-22 09:55AM
Oct-11-22 04:05PM
Oct-10-22 08:48AM
Oct-05-22 09:25AM
Oct-03-22 06:45AM
Sep-26-22 09:21AM
Sep-21-22 08:00AM
Aug-24-22 06:15AM
Aug-18-22 08:50AM
Aug-10-22 01:20PM
Aug-09-22 06:05PM
Aug-04-22 10:00AM
Aug-03-22 07:00AM
Aug-02-22 10:00AM
Jul-27-22 11:15AM
Jul-12-22 04:05PM
Jul-11-22 10:14AM
Jun-29-22 11:04AM
Jun-23-22 08:52AM
Jun-20-22 08:53AM
Jun-05-22 08:21AM
May-25-22 03:00PM
May-13-22 06:06AM
May-11-22 12:54PM
May-10-22 05:45PM
May-09-22 09:37AM
May-03-22 03:00PM
Apr-26-22 04:05PM
Apr-25-22 01:23PM
Apr-12-22 04:05PM
Apr-08-22 01:05PM
Feb-25-22 07:00AM
Feb-24-22 04:05PM
Feb-23-22 04:05PM
Feb-11-22 06:58PM
AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company had discovery programs that are either completed, in progress, or under contract with partners. It has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hansen Carl L. G.Chief Executive OfficerMay 26Option Exercise2.7056,125151,538561,250May 30 01:14 PM
Thermopylae Holdings Ltd.10% OwnerMay 26Buy6.52153,000997,72856,012,493May 26 02:50 PM
Booth AndrewChief Financial OfficerMay 26Buy6.8514,50099,325153,000May 26 02:53 PM
Lecault VeroniqueChief Operating OfficerMay 05Option Exercise0.19250,00047,5002,020,122May 09 03:02 PM
Hansen Carl L. G.Chief Executive OfficerFeb 22Option Exercise2.7056,125151,538505,125Feb 23 04:33 PM
Booth AndrewChief Financial OfficerDec 20Option Exercise0.1950,0009,500188,500Dec 22 02:31 PM
Thermopylae Holdings Ltd.10% OwnerDec 16Buy10.1085,102859,24955,859,493Dec 20 10:18 AM
Hansen Carl L. G.Chief Executive OfficerNov 18Option Exercise2.7056,125151,538449,000Nov 21 09:36 PM
Thermopylae Holdings Ltd.10% OwnerAug 19Buy11.46200,0002,292,46055,844,391Aug 22 03:27 PM
Hansen Carl L. G.Chief Executive OfficerAug 18Option Exercise2.7056,125151,538392,875Aug 22 03:09 PM
Thermopylae Holdings Ltd.10% OwnerJun 14Buy8.059,17373,84255,644,391Jun 15 01:14 PM
Thermopylae Holdings Ltd.10% OwnerJun 13Buy8.0354,915441,06655,635,218Jun 15 01:14 PM
Thermopylae Holdings Ltd.10% OwnerJun 06Buy7.5064,545483,96555,580,303Jun 08 03:32 PM